Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam with etomidate vs propofol for painless gastroenteroscopy
ChiCTR2400085904Phase 4Completed
- Sponsor
- Affiliated Qingdao Central Hospital of Qingdao University
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in None comparing Remimazolam + etomidate with Remimazolam + propofol (2 arms). Primary endpoint: respiratory depression. Started Jun 2024; status: completed.
02
Drugs
remimazolametomidatepropofol
Beyond the preview
Go deeper on ChiCTR2400085904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400085904.